These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2560849)

  • 21. [Early summer meningoencephalitis. Only vaccination offers protection].
    Paukstadt W
    MMW Fortschr Med; 2004 Jun; 146(26):10. PubMed ID: 15529681
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activity of cytokines in immunization with a vaccine against experimental tick-borne encephalitis].
    Ignat'ev GM; Otrashevskaia EV; Vorob'eva MS
    Vopr Virusol; 2003; 48(2):22-5. PubMed ID: 12924094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early tick-borne meningoencephalitis infections occur already in March. Pediatric vaccine is available again].
    MMW Fortschr Med; 2002 Mar; 144(11):58. PubMed ID: 12066518
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Active immunization against tick-borne encephalitis in the elderly].
    Biró J; Regius O
    Z Gerontol; 1985; 18(6):337-9. PubMed ID: 3879415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis.
    Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB
    Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus].
    Sokolova ED; Kamalov II; Konovalov GV
    Vopr Virusol; 1994; 39(5):220-3. PubMed ID: 7716907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies.
    Bender A; Jäger G; Scheuerer W; Feddersen B; Kaiser R; Pfister HW
    J Neurol; 2004 Mar; 251(3):353-4. PubMed ID: 15015020
    [No Abstract]   [Full Text] [Related]  

  • 30. A tick-borne encephalitis vaccine without human serum albumin as stabilizer.
    Bröker M; Zent O
    Vaccine; 2005 Dec; 23(50):5699. PubMed ID: 16226355
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live virus vaccines: something old, something new, something borrowed..
    Dubensky TW; Polo JM; Liu MA
    Nat Med; 1998 Dec; 4(12):1357-8. PubMed ID: 9846565
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
    Pazdiora P; Januska J
    Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectors of in vivo delayed hypersensitivity in experimental flavivirus infections and vaccination against tick-borne encephalitis in mice].
    Lipovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):83-8. PubMed ID: 6098109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model.
    Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM
    Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Persistence of the tick-borne encephalitis virus in the vaccinated organism].
    Levina LS; Pogodina VV
    Vopr Virusol; 1988; 33(4):485-90. PubMed ID: 3195146
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.